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 Abstract 21 
Many drug candidates today have a low aqueous solubility, and hence may show a low oral 22 
bioavailability, presenting a major formulation and drug delivery challenge. One way to increase the 23 
bioavailability of these drugs is to use a supersaturating drug delivery strategy. The aim of this study 24 
was to develop a video-microscopic method, to evaluate the effect of a precipitation inhibitor on 25 
supersaturated solutions of the poorly soluble drug tadalafil, using a novel video microscopic small 26 
scale setup. Based on preliminary studies, a degree of supersaturation of 29 was chosen for the 27 
supersaturation studies with tadalafil in FaSSIF. Different amounts of HPMC were predissolved in 28 
FaSSIF to give four different concentrations, and the supersaturated system was then created using a 29 
solvent shift method. Precipitation of tadalafil from the supersaturated solutions was monitored by 30 
video-microscopy as a function of time. Single-particle analysis was possible using commercially 31 
available software, however, to investigate the entire population of precipitating particles (i.e. their 32 
number and area covered in the field of view) an image analysis algorithm was developed (multi-33 
particle analysis). The induction time for precipitation of tadalafil in FaSSIF was significantly 34 
prolonged by adding 0.01 % (w/v) HPMC to FaSSIF, and the maximum inhibition was reached at 0.1 35 
% (w/v) HPMC, after which additional HPMC did not further increase the induction time. The single- 36 
and multi-particle analyses yielded the same ranking of the HPMC concentrations, regarding the 37 
inhibitory effect on precipitation. The developed small scale method to assess the effect of precipitation 38 
inhibitors can speed up the process of choosing the right precipitation inhibitor and the concentration to 39 
be used.  40 
1. Introduction 41 
 42 
It has been estimated that approximately 75 - 90 % of low molecular weight drug candidates in development can be considered 43 
poorly soluble in water (1-3), often leading to low and inconsistent bioavailability. Therefore, there is a growing need for 44 
formulation strategies enabling increased oral bioavailability. One such strategy is the use of supersaturating drug delivery systems 45 
which can induce supersaturation, e.g. in the small intestine (4, 5).  46 
In a supersaturated system, the drug concentration exceeds the equilibrium solubility of the drug thus, increasing the free drug 47 
concentration available for absorption in the small intestine. According to Fick’s law, an increased free drug concentration will 48 
lead to a higher flux and hence, a higher absorption. A common way to describe a supersaturated system is to use the degree of 49 
supersaturation (DS). DS is defined as the ratio between the concentration in the supersaturated solution and the thermodynamic 50 
equilibrium solubility of the drug in the same medium (6):  51 
                                                       𝐷𝐷𝐷𝐷 = 𝐶𝐶𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
𝐶𝐶𝑠𝑠𝑒𝑒𝑠𝑠𝑠𝑠𝑒𝑒𝑠𝑠𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑒𝑒
                         (Eq. 1) 52 
 53 
Supersaturated systems are thermodynamically unstable and will inevitably be driven towards equilibrium solubility over time, 54 
which poses a significant challenge for the formulation work using such systems (4). In a supersaturated solution, the equilibrium 55 
will be restored by precipitation of the drug, which will, consequently, lower the free drug concentration available for absorption.  56 
The precipitation process can be split into two sub-processes, having their own kinetics, i.e. nucleation and crystal growth (7). 57 
Nucleation happens when molecules interact to form a cluster of a critical radius. This critical cluster formation requires a specific 58 
amount of energy. Once a nucleus has been formed and starts to grow, the process is irreversible and crystal growth occurs. 59 
Nucleation occurs prior to crystal growth; however, nucleation continues to occur following the formation of the first nucleus 60 
making it difficult to distinguish the nucleation and crystal growth kinetics from each other (7). The induction time (tind), being the 61 
time point at which the first precipitate is formed, is often used as a proxy to describe the nucleation process. In case of a 62 
supersaturating drug delivery strategy, it is desired to prolong the time until precipitation, and hereby, the duration of the existence 63 
of a supersaturated system. This can be achieved by introducing an excipient to reduce or inhibit precipitation, a so called 64 
precipitation inhibitor (PI) (4). Polyvinylpyrrolidone (PVP) (8), (hydroxypropyl)methyl cellulose (HPMC) (9), and cyclodextrins 65 
such as sulfobutyl-ether β-cyclodextrin (10) are commonly used as PIs. The PIs act either by decreasing nucleation or crystal 66 
growth rate (or both) through various pathways (4). HPMC is often used as a PI in pharmaceutical studies (6, 10-12) and it has 67 
previously been shown to delay the onset of precipitation (i.e. to prolong tind) of different drugs such as tadalafil (6), dapivirine 68 
(10), and RS-8359 (13). Several mechanisms of action have been proposed; the effect of HPMC may be due to hydrogen-bonding 69 
between the polymer and the drug (this would lead to a reduction in the nucleation kinetics) (9, 14), or adsorption of HPMC to the 70 
crystal surface of a growing crystal (this would reduce the crystal growth kinetics) (15). HPMC and other polymers may also work 71 
as precipitation inhibitors by increasing the viscosity of the dissolution medium, hereby reducing molecular mobility and diffusion 72 
coefficient of the precipitating drug (4). Addition of HPMC to the dissolution medium has also been shown to change the crystal 73 
structure of the precipitate of several drugs compared to a PI-free system (16), further indicating the presence of molecular 74 
interactions between the drug and the polymer during the precipitation process. It is generally known that the effect of a PI is very 75 
drug specific, and the optimal type and concentration of polymer to inhibit precipitation of a supersaturated solution will vary, 76 
depending on the drug of interest (8, 12, 17).  Warren et al. (12) investigated combinations of 42 polymers and three drugs and 77 
found very different effects on the same drug depending on polymer type, concentration and grade used as PI. Hence, it will be 78 
necessary to test several polymers in different concentrations before choosing the optimal PI type, concentration and grade for a 79 
given drug, and therefore a high-throughput, small scale setup to study precipitation kinetics is highly needed. 80 
 81 
Precipitation studies are conventionally performed in a regular dissolution setup where the drug concentration is monitored over 82 
time (18), and the detection of precipitation is often based on a decrease in drug concentration in solution and not on the formation 83 
of particles. A direct way of studying precipitation is the use of microscopic methods. The advantage of a microscopic approach is 84 
the direct visualization of the precipitate, instead of the use of a surrogate marker (concentration of dissolved drug using e.g. in situ 85 
UV measurements). This gives the opportunity to investigate the early stages of precipitation where the amount of precipitate is 86 
not sufficient for a baseline shift due to light scattering in the visible range of the electromagnetic spectrum.  87 
Previously, microscopy has been used to investigate precipitation in supersaturated gels over a period of days (9). Conventional 88 
microscopy, however, is time consuming and labour intensive, and therefore more automated methods have been developed for 89 
different purposes. For example, Wu et al. (19) have developed a method for online monitoring of nucleation and crystal growth 90 
using polarized light microscopy and subsequent image analysis, and recently, a method describing single pellet dissolution in a 91 
24-well plate using video-microscopy has been published, and it was found that this method had an excellent correlation to UV 92 
measurements (20). 93 
The combination of conventional microscopy and video analysis has furthermore been used for investigations of bacterial 94 
growth (21), in a commercially available 96-well plate setup called the oCelloScopeTM, specifically developed for this purpose.  95 
The aim of the current study was to develop a video-microscopic tool to screen for the effect of PIs for early drug development 96 
using this equipment. The model systems consisted of supersaturated solutions of the poorly-water soluble drug tadalafil and 97 
HPMC as PI.  98 
 99 
2. Materials and Methods 100 
 101 
2.1 Materials 102 
Fasted state simulated intestinal fluid (FaSSIF) powder was purchased from biorelevant.com (London, UK). Tadalafil was 103 
purchased from AK Scientific (Union City, Ca, USA). Sodium chloride, monobasic sodium phosphate dihydrate and dimethyl 104 
 sulfoxide (DMSO) were acquired from Merck Millipore (Darmstadt, Germany). Sodium hydroxide was obtained from VWR 105 
Chemicals (Leuven, Belgium) and hydroxypropyl methyl cellulose (HPMC, Pharmacoat 606 6 cp) was purchased from Shin Etsu 106 
(Tokyo, Japan). Nunc 96-well microplates with Nunclon Delta Surface were obtained from Thermo Fisher Scientific (Waltham, 107 
MA, USA). Q-max RR syringe filters were acquired from Frisenette (Knebel, Denmark). 108 
 109 
2.2 Methods 110 
2.2.1 Equilibrium solubility of tadalafil  111 
The solubility of tadalafil in FaSSIF + 13 % (v/v) DMSO and FaSSIF + 13 % (v/v) DMSO + HPMC in increasing 112 
concentrations were investigated using a shake-flask method at room temperature. FaSSIF containing 13 % (v/v) DMSO was 113 
prepared by adding 1.5 mL DMSO to 10 mL of FaSSIF. Then excess tadalafil (>10x equilibrium solubility) was added. The 114 
suspension was shaken for 24 h and samples were taken at three time points during the experiment (3 h, 22 h and 24 h after 115 
starting the experiment). The samples were filtered through a 0.22 µm PTFE Hydrophilic filter (Q-Max RR Syringe Filter) prior to 116 
quantification by high-performance liquid chromatography (HPLC). All experiments were performed in triplicate. Analysis was 117 
performed on a C18 column (Kinetix XB-C18, 5µm, Phenomenex, (Torrance, California, U.S)) with a mobile phase of 0.1 % (v/v) 118 
trifluoroacetic acid in 40:60 acetonitrile:water (v/v) in a Dionex HPLC with UV detection at 284 nm.   119 
 120 
2.2.2 Preparation of a supersaturated tadalafil solution in FaSSIF 121 
FaSSIF was prepared according to the instructions of the manufacturer and HPMC (0.0 – 0.5 % w/v) was added. The mix was 122 
stirred overnight in order for the polymer to equilibrate in the medium (22).  123 
The studies were conducted in 96-well microplates at room temperature by spiking 30 µL of a tadalafil-DMSO stock solution (5 124 
mg/mL) into 200 µL FaSSIF with or without predissolved HPMC, to induce a supersaturated tadalafil solution with a 125 
concentration of 652 µg/mL (DS = 29). The solution was mixed by pipetting up and down two times when spiking tadalafil into 126 
the FaSSIF filled well. The molecular weight of HPMC was 36 kDa (23) and the molar drug:polymer ratio spanned from 14-7030.  127 
  128 
2.2.3 oCelloScopeTM setup  129 
The precipitation studies were performed on an oCelloScope SystemTM (Philips Biocell A/S, Allerød, Denmark). This system is 130 
a video-microscopic setup creating a series of micrographs using time-lapse technology, as described by Fredborg et al. (21). The 131 
experiments were performed in 24 replicates for each HPMC concentration. For obtaining 24 replicates in total, 3 or 4 experiments 132 
were run simultaneously 8 or 6 times. The illumination level and focus were set manually and adjusted individually before each 133 
experiment to ensure high micrograph quality for the subsequent image analysis. The illumination level interval varied from 300-134 
400 and the focus from 2800-2990 depending on the experiment, and the illumination time was kept constant at 2 ms throughout 135 
all experiments. Twenty micrographs were acquired of each well at every time point creating an 855 µm length of the scan and 136 
thereby, covering 1.49 mm2 of the well. The number of repetitions and the repetition intervals were chosen depending on the 137 
concentration of HPMC, and designed to cover a period of 22 min. Around the tind, micrographs were acquired every 20 s. 138 
 139 
2.2.4 Single-particle analysis 140 
Micrographs acquired by the oCelloScope™ were analysed with the UniExplorer software version 6.0, accompanying the 141 
equipment (Philips Biocell A/S, Allerød, Denmark). Using the segmentation tool in UniExplorer software, the areas of the 142 
individual particles for every measurement time point were calculated. The tind was determined as the time point where the 143 
software identified the first particle in focus. Crystal growth was determined from the area of one well-defined particle, often the 144 
first particle to appear, calculated by the software. The particle areas were exported and further data treatment was performed 145 
using Excel 2010 (Microsoft Office, Wa, USA). Visualization and statistical analysis were performed using GraphPad Prism 146 
version 6.0 (GraphPad software Inc. Ca, USA). Statistical differences were determined using one-way ANOVA with a Sidak 147 
multiple comparison test. 148 
 149 
2.2.5 Multi-particle analysis  150 
In contrast to the single-particle analysis, multi-particle analysis determined crystal growth from the area of all the particles 151 
precipitating within the field of view. The areas covered by particles were segmented using UniExplorer’s gradient segmentation 152 
algorithm and the H-minima Transform algorithm (24). From the segmented areas, crystal growth was then quantified as the 153 
percentage of the total micrograph area covered by the particles and as the number of particles. The number of particles was 154 
counted automatically using the two stage circular Hough transform (25). With this approach circles were fitted to the segmented 155 
areas, where the number of fitted circles corresponded to the number of particles in the micrograph.  156 
 3. Results and Discussion 157 
 158 
3.1 Solubility, micrograph quality and morphology  159 
The equilibrium solubility of tadalafil was investigated in FaSSIF containing 13 % (v/v) DMSO with and without addition of up 160 
to 1 % (w/v) HPMC. The solubility was found to be 22.5 ± 1.6 µg/mL, and addition of HPMC did not increase the solubility 161 
significantly (p > 0.05).   162 
The precipitation kinetics of the supersaturated tadalafil solutions were monitored using the oCelloScope™ set-up. Figure 1A-C 163 
shows micrographs of pure FaSSIF, a precipitated tadalafil suspension in FaSSIF and a precipitated tadalafil suspension in FaSSIF 164 
with 0.5 % (w/v) HPMC after 14 min, respectively. The presence of 0.5 % (w/v) HPMC clearly decreased the number of 165 
precipitated particles in the frame observed after 14 min compared to the tadalafil suspension in FaSSIF. The difference in 166 
background colour is due to different illumination settings. Pure FaSSIF (Figure 1A) contained silhouettes of larger structures of 167 
approximately 100 µm, however these silhouettes in pure FaSSIF were clearly distinguishable from the precipitate of tadalafil in 168 
FaSSIF. The darker blurry areas of the micrographs in Figure 1B and C were most likely precipitated particles out of focus.  169 
The precipitate in pure FaSSIF (orange arrow, Figure 1B) had a round and compact core with a less dense outer layer (Figure 170 
1B), whereas the precipitate in FaSSIF with 0.5 % (w/v) HPMC (blue arrow, Figure 1C) appeared less dense and less regular. 171 
However, later appearing particles in pure FaSSIF (green arrow, Figure 1B) were similar to the less dense particles found in 172 
FaSSIF with HPMC.  173 
Tadalafil has previously been shown to precipitate in a crystalline form (6), and similar differences in precipitate morphology 174 
have been observed for other compounds (7). For studying the morphology of the precipitate, Lindfors et al. (7) prepared 175 
supersaturated solutions of bicalutamide, let them stand for a minimum of 72 h to precipitate before taking images to analyse 176 
morphology and number of particles manually. Crystallization of the supersaturated bicalutamide system without PVP led to a 177 
star-like morphology of the particles, whereas more compact and spherical particles were formed in the presence of 0.01 % (w/w) 178 
PVP as PI (7). Furthermore, Lindfors et al. (7) reported morphology differences in precipitate particles formed without PI present 179 
dependent on the age of the particles, similar to the precipitate morphology observed for tadalafil (Figure 1B).  180 
 181 
Figure 1. Micrographs from the oCelloScopeTM. A: pure FaSSIF, B: 652 µg/mL tadalafil in FaSSIF (t: 14.1 min), C: 652 µg/ml tadalafil 182 
in FaSSIF with 0.5 % (w/v) HPMC (t: 14.8 min). t is the time after tadalafil was added to FaSSIF. The difference in background colour is 183 
due to different illumination settings between the runs. The orange and the green arrow illustrate an example of early and later appearing 184 
precipitate in pure FaSSIF, respectively. The blue arrow illustrates precipitate in FaSSIF with HPMC.  185 
  186 
3.2 Single-particle analysis 187 
As described above, precipitation comprises of two processes, namely nucleation and crystal growth. The appearance of the first 188 
particle can be used as a measure for tind and hence, to assess the effect of HPMC on nucleation. This time point was measured 20 - 189 
24 times for each of the HPMC concentrations (Figure 2). The tind for tadalafil in FaSSIF was 4.5 ± 0.9 min (Figure 2), and the 190 
addition of 0.001 % (w/v) HPMC to the dissolution medium did not significantly prolong this time (5.1 ± 1.5 min, p > 0.05). In 191 
contrast, with the addition of 0.01, 0.1 or 0.5 % (w/v) of HPMC to the dissolution medium, the tind for tadalafil in FaSSIF was 192 
significantly prolonged compared to tadalafil in FaSSIF without HPMC at the same level of supersaturation (Figure 2). For 0.01 % 193 
(w/v) HPMC, the tind was prolonged to 6.2 ± 2.0 min. Increasing the concentration of HPMC 10-fold further prolonged the tind, but 194 
the effect plateaued at a tind of about 9.5 min. A HPMC concentration of 0.5 % (w/v) resulted in a tind similar to the one observed 195 
with 0.1 % (w/v) HPMC present, albeit with a markedly reduced standard deviation (Figure 2).  196 
It should be noted that the minimum detectable particle size is 0.5 µm according to the technical specifications of the system, 197 
and thus the precipitation will have started already before any particles become visible. This will result in a lag time between the 198 
initial time of nucleation and the time point where the particles have reached a detectable size. However, as tind is defined here as 199 
the timepoint where the software identifies the first particle in focus, the determination was consistent for all measurements. The 200 
tind is used for comparative purposes, and not for exact modelling or extrapolation of initial nucleation, and hence, a consistent 201 
estimate is considered adequate. 202 
 203 
Figure 2. tind for tadalafil in FaSSIF with different concentrations of predissolved HPMC observed with the single-particle analysis 204 
method (mean ± SD). For each concentration of HPMC the experiment was repeated 20-24 times. The * indicates a significant difference 205 
from the tind for tadalafil in FaSSIF without HPMC (p < 0.05). The # indicates a significant difference from the tind for tadalafil in FaSSIF 206 
with 0.01 % (w/v) HPMC (p < 0.05). 207 
The growth of tadalafil particles in FaSSIF, plotted as a function of time, with different concentrations of predissolved HPMC is 208 
shown in Figure 3. The graph for each concentration of HPMC represents the growth of a single well-defined particle from 24 209 
replications of the experiment. For tadalafil in FaSSIF without HPMC, the first particle appears after 5 min, corresponding to the 210 
tind in Figure 2 and hereafter, a linear growth in area is observed until the end of the study (22 min). The growth rate of tadalafil 211 
was not significantly decreased in FaSSIF with 0.001 % (w/v) HPMC. Maximal inhibition of the growth rate was reached with 212 
0.01 % (w/v) HPMC, and no further decrease in the crystal growth was achieved with higher HPMC concentrations (0.1 and 0.5 % 213 
(w/v)). In a different setup, the size of a single representative particle has previously been used to investigate dissolution 214 
phenomena. Svanbäck et al. (20) showed an excellent correlation between the dissolution measured by UV spectroscopy and the 215 
reduction in particle size followed via video-microscopy, indicating that a single particle in principle can be used to explain the 216 
behaviour of a population of particles.  217 
  218 
Figure 3. Area of single well-defined tadalafil particles in FaSSIF with different concentrations of predissolved HPMC as a function of 219 
time (mean ± SD). For each of the HPMC concentrations the experiment was repeated 24 times, one well-defined particle was followed 220 
each time, and the individual area of the particle was calculated (n = 3-24).  = 0.0 % (w/v),   = 0.001 % (w/v), = 0.01 % (w/v),  = 221 
0.1 % (w/v),  = 0.5 % (w/v) HPMC.  222 
 223 
 224 
3.3 Multi-particle analysis 225 
Whilst the single-particle analysis focused on one early appearing particle, growth of only a selected particle may not be 226 
representative for the overall growth. To be able to describe the entire population of particles, and thus to include more data in the 227 
data analysis, an algorithm was developed to detect the appearing particles and calculate their areas (section 2.2.5). The induction 228 
time is defined as the first detection of a particle by the algorithm, and the same micrograph before and after segmentation is 229 
shown in Figure 4. The multi-particle analysis was able to find the majority of the particles. It is worth to note that the circular 230 
Hough transform used for particle counting was incapable of finding particles of which the geometric centers were outside the 231 
micrograph (Figure 4B). However, this was not considered an issue for the growth analysis as this was consistent and had no 232 
impact on the area measurement. 233 
  234 
Figure 4. A:  652 µg/mL tadalafil in FaSSIF with 0.001 % (w/v) HPMC (t: 13.2 min), B: the same micrograph after segmentation, where 235 
the red section describes the area of the particles and the yellow circles are used to count the particles using the multi-particle analysis. 236 
 237 
Using this algorithm, the tind for tadalafil in FaSSIF, without HPMC, was found to be 4.6 ± 0.7 min (Figure 5). In the presence of 238 
0.001 % (w/v) HPMC no significant difference in tind was observed (5.4 ± 1.1 min, p < 0.05), when compared to the tind for 239 
tadalafil in pure FaSSIF. A significantly prolonged tind was, however, observed for tadalafil in FaSSIF with 0.01 or 0.1 (w/v) 240 
HPMC (7.1 ± 1.8 min and 9.2 ± 1.7 min, respectively), whereas a plateau effect was observed with the addition of 0.5 % (w/v) 241 
HPMC (9.5 ± 1.1 min, p < 0.05), as this did not further prolong the tind significantly compared to 0.1% (w/v) HPMC. These 242 
induction times were consistent with the results observed for the single-particle analysis (Figure 2).  In a recent study, the effect of 243 
HPMC (0.05 % w/v) on the nucleation of tadalafil in FaSSIF was investigated by a solvent shift method in a dissolution setup (6), 244 
and these authors also found that HPMC had a pronounced effect on the nucleation of tadalafil in FaSSIF and significantly 245 
prolonged the tind. These results correspond very well with those of the current study, even though the method used was very 246 
different. PI effects of HPMC have also been shown using amorphous solid dispersions as a method to induce supersaturation for 247 
tadalafil. An increase in HPMC concentration (1:1 – 1:8 w/w ratio of drug to polymer, corresponding to 0.013 % w/v – 0.024 % 248 
w/v HPMC in the dissolution medium) resulted in an increase in the maximum dissolved drug concentration achieved during a 249 
dissolution study and a retardation of drug precipitation in water (3).  250 
A similar plateau effect of HPMC on the tind has previously been reported for the compound RS-8359, in a dissolution setup 251 
(13), where the precipitation was inhibited by adding 0.001 % (w/v) HPMC, but the effect did not further improve by addition of 252 
up to 0.1 % (w/v) HPMC.  253 
 254 
  255 
Figure 5. tind for tadalafil in FaSSIF with different concentrations of predissolved HPMC observed with the multi-particle analysis 256 
algorithm (mean ± SD). For each concentration of HPMC the experiment was repeated 24 times. The * indicates a significant difference 257 
from the tind for tadalafil in FaSSIF without HPMC (p < 0.05). The # indicates a significant difference from the tind for tadalafil in FaSSIF 258 
with 0.01 % (w/v) HPMC (p < 0.05). 259 
 260 
The multi-particle analysis described the nucleation and subsequent crystal growth of the entire investigated area (Figure 6). 261 
Until approximately 10 min, no significant difference in the growth of tadalafil particles with and without the presence of HPMC 262 
was observed. However, after 10 min, a clear difference was observed in the growth trend of tadalafil particles in the different 263 
investigated systems. With 0 and 0.001 % (w/v) HPMC present, a steep growth curve was observed after 10 min and continued 264 
throughout the study (22 min). With 0.01 - 0.5 % (w/v) HPMC present, the nucleation and crystal growth of tadalafil seemed to be 265 
inhibited for approximately 13 min, and after 15 min the growth of tadalafil particles increased. When analysing the area covered 266 
by precipitated tadalafil, a maximum inhibitory effect therefore was obtained already with only 0.01 % (w/v) HPMC present, 267 
which was also concluded from the single-particle analysis. A maximum inhibitory effect of HPMC around 0.01 % (w/v) has also 268 
been described for RS-8359 (13), but a further increase in HPMC concentration lead to faster precipitation.  269 
 270 
Figure 6. Percentage of the micrograph covered by tadalafil particles in FaSSIF with different concentrations of HPMC as a function of 271 
time. The growth kinetics are shown as the area (%) of a micrograph covered by particles, calculated with the multi-particle analysis 272 
(mean ± SD, n=24).  = 0.0 % (w/v),   = 0.001 % (w/v), = 0.01 % (w/v),  = 0.1 % (w/v),  = 0.5 % (w/v) HPMC. 273 
 274 
Another way to describe the particle population is to count the total number of particles, e.g. describing the number of nucleated 275 
particles. The number of tadalafil particles at three different time points, 10.0 min, 14.5 min and 17.5 min is shown in Figure 7. 276 
 For FaSSIF without addition of HPMC and for the lowest HPMC concentration (0.001 % (w/v)), an increase in the particle count 277 
from 10 to 14.5 min was observed, but not from 14.5 to 17.5 min. However, for 0.01 % (w/v) HPMC, the rate of particle formation 278 
was constant throughout the three time points. For the high HPMC concentrations (0.1 - 0.5 % (w/v)) very few particles at 10 and 279 
14.5 min were observed however, there were significantly more particles at the last time point (17.5 min) (p < 0.05). This 280 
corresponds well to the observations in Figure 5, where the first particles appear after approximately 10 min, for 0.1 and 0.5 % 281 
(v/w) HPMC. Hence, by adding 0.01 % (w/v) of HPMC to FaSSIF, it was possible to significantly inhibit both nucleation and 282 
crystal growth of tadalafil (Figure 6), however 0.1 % (w/v) HPMC was needed to obtain maximal inhibitory effect of HPMC on 283 
nucleation alone (Figure 5). For felodipine, it was possible to inhibit precipitation using HPMC concentrations two times lower 284 
than the ones used in the current study (26). Hence, as described in the introduction, the optimum polymer concentration for 285 
precipitation inhibition is drug dependent. 286 
 287 
Figure 7. Histogram showing the number of particles (mean ± SD) present at 10, 14.5 and 17.5 min (± 0.5 min) for a supersaturated 288 
tadalafil suspension in FaSSIF with 0 – 0.5 % (w/v) HPMC (n = 24).  = 0.0 % (w/v),   = 0.001 % (w/v),  = 0.01 % (w/v),  = 0.1 % 289 
(w/v),  = 0.5 % (w/v) HPMC. 290 
 291 
The developed method can be used as a screening tool to evaluate the effect of a PI on supersaturation. The effect of a PI on 292 
supersaturation of a given poorly water-soluble drug is valuable information during the preformulation phase. As described in the 293 
introduction, the effect of a PI is very drug specific, and it will often be necessary to screen several PI types, concentrations and 294 
grades before deciding on the optimal supersaturating system for a given drug. Thus, the information from this work provides 295 
qualitative knowledge about the effect of a PI on supersaturation, which can be used as an efficient and highly needed screening 296 
tool for the improvement of oral absorption of poorly water-soluble drugs using supersaturating systems. 297 
Furthermore, the micrographs can give important information about the morphology and number of particles, whilst non-298 
microscopy methods, e.g. dissolution and dynamic light scattering, do not provide the same level of detail or understanding of the 299 
system. For instance, morphological differences in the precipitating particles in the presence or absence of a PI can be an 300 
indication for molecular interactions between the drug and the PI. The possibility of using 96-well plates in an automatized setup 301 
offers the potential for an effective high-throughput method where only small amounts of drug and PI are needed. Thus, this 302 
method is less time consuming and labour intensive, but yields comparable results to existing setups, e.g. conventional 303 
microscopy, where only one sample at a time can be measured (9, 19).  304 
 305 
However, like any other setup, this method has its limitations. It takes the oCelloScopeTM approximately 3 min to screen a 96-306 
well plate. Determination of tind may require micrographs taken more frequently, and due to the lag time, this will be an estimate 307 
for tind. Nevertheless, for comparative measurements and as an initial tool to screen polymers for their PI effect, this is not 308 
considered a problem and the developed method appears appropriate. 309 
 310 
3.4 Future perspective of the algorithm  311 
The current image analysis is optimized for spherical particles; however, drug precipitates may have other shapes, for instance, 312 
carbamazepine forms needle-like structures and algorithms to account for this type of structures could be implemented, as 313 
proposed by Wu et al. (27). This proof-of-principle study has shown that it is possible to use the oCelloScope™ as a screening tool 314 
 of the effect of PIs in supersaturation studies. Future studies should include tracking of the particles over time which would enable 315 
conduction of single-particle analysis without any bias from manual selection. Optical flow algorithms like Farnebäck’s flow 316 
algorithm (28) would probably solve this.  317 
 318 
4. Conclusion 319 
A novel small scale high-throughput method has been developed to study the effect of precipitation inhibitors on poorly-water 320 
soluble drugs in supersaturated systems. A single-particle analysis was possible using commercially available software; however, 321 
to investigate the entire population of particles an algorithm for multi-particle analysis was designed. The data output was 322 
comparable between the two methods of analysis and yielded the same ranking of the inhibitory effect on precipitation of the 323 
different HPMC concentrations. Analysis of the data showed that 0.01 % (w/v) HPMC was sufficient to delay both nucleation and 324 
crystal growth of tadalafil in FaSSIF, however 0.1 % (w/v) HPMC was needed to obtain maximal inhibitory effect of HPMC on 325 
nucleation alone.  326 
 327 
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